This report studies the global Next Generation Cancer Diagnostics market, analyzes and researches the Next Generation Cancer Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Cepheid
Koninklijke Philips N.V
F. HoffmannLa Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Get More Information about this Report @ https://www.planetmarketreports.com/reports/next-generation-cancer-diagnostics-market-83
Market segment by Type, the product can be split into
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
Market segment by Application, Next Generation Cancer Diagnostics can be split into
Hospitals
Clinics
Other
Get a Free Sample Copy of this report @ https://www.planetmarketreports.com/report-sample/next-generation-cancer-diagnostics-market-83
Table of Contents
Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2025
1 Industry Overview of Next Generation Cancer Diagnostics
2 Global Next Generation Cancer Diagnostics Competition Analysis by Players
2.1 Next Generation Cancer Diagnostics Market Size Value by Players 2013-2018
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company Top Players Profiles
3.1 Cepheid
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.1.5 Recent Developments
3.2 Koninklijke Philips N.V
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.2.5 Recent Developments
3.3 F. HoffmannLa Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.3.5 Recent Developments
3.4 Qiagen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.5.5 Recent Developments
3.6 Abbott
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.6.5 Recent Developments
3.7 Thermo Fisher Scientific
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.7.5 Recent Developments
3.8 Opko Health
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.8.5 Recent Developments
3.9 Myriad Genetics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.9.5 Recent Developments
3.10 Agilent Technologies
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Cancer Diagnostics Revenue Million USD 2013-2018
3.10.5 Recent Developments
3.11 GE Healthcare
3.12 PerkinElmer
3.13 Genomic Health
3.14 Illumina
3.15 Hologic
3.16 Almac Group
3.17 Janssen Global Services
3.18 Sysmex Corporation
4 Global Next Generation Cancer Diagnostics Market Size by Type and Application 2013-2018
4.1 Global Next Generation Cancer Diagnostics Market Size by Type 2013-2018
4.2 Global Next Generation Cancer Diagnostics Market Size by Application 2013-2018
4.3 Potential Application of Next Generation Cancer Diagnostics in Future
4.4 Top Consumer/End Users of Next Generation Cancer Diagnostics
5 United States Next Generation Cancer Diagnostics Development Status and Outlook
5.1 United States Next Generation Cancer Diagnostics Market Size 2013-2018
5.2 United States Next Generation Cancer Diagnostics Market Size and Market Share by Players 2013-2018
5.3 United States Next Generation Cancer Diagnostics Market Size by Application 2013-2018
To Browse Similar Reports @ http://www.planetmarketreports.com/category/medical-devices
About Us :
Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.
We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports